Abstract:A new series of thioethers containing a 1,2,4-oxadiazole ring were synthesized by the modified Riemschneider reaction. The corresponding thiocyanate derivatives of 1,2,4-oxadiazoles were obtained in good yields by the reaction of 3-aryl-5-chloromethyl-1,2,4-oxadiazole compounds with NH 4 SCN in triethylene glycol at 60 °C as a new method. Thioether derivatives were synthesized by reacting 5-thiocyanato-3-aryl-1,2,4-oxadiazole with various tertiary or secondary alcohols in solvent-free conditions for 10–30 min at 60 °C. The synthesized compounds were characterized by various spectroscopic methods (FTIR, 1 H NMR, 13 C NMR, and HRMS). All 1,2,4-oxadiazole-thioethers were tested for xanthine oxidase (XO), acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibition potential. The results showed that 4 h has more potential inhibition activity than positive control for XO (IC 50 = 0.41 ± 0.067 μM) and AChE/BChE (IC 50 = 0.95 ± 0.42 μM/1.49 ± 0.45 μM) and is considerably greater than other compounds. Moreover, our experimental study was supported by molecular docking to describe the binding mode of new structures to enzymes. The molecular docking calculations showed that molecules with high binding energy with at least one enzyme were 4b, 4d, 4g, 4h, 4i, 4j, 4k, and 4l. The physicochemical, ADMET, and drug-likeness parameters were computed using the SwissADMET online program. In silico studies of the molecules demonstrated that five molecules, 4b, 4d, 4g, 4h, and 4l, had relatively optimum drug similarity and medicinal chemistry properties. The five molecules synthesized and characterized in this study can be further investigated as drug or drug-like compound candidates.

Synthesis and biological evaluation of oxoapratoxin E and its C30 epimer

Synthesis and biological activity of novel 1,3,4-oxadiazole derivatives containing a pyrazole moiety

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Total Synthesis and Biological Evaluation of Apratoxin E and Its C30 Epimer: Configurational Reassignment of the Natural Product

Divergent Synthesis of Revised Apratoxin E, 30-epi-Apratoxin E, and 30S/30R-Oxoapratoxin E

Synthesis, Conformational Analysis and Biological Evaluation of the Lactam Analogue of the Cyclodepsipeptide Apratoxin A

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Syntheses and Insecticidal Activity of Spirocyclic Tetronic Acid Derivatives Containing Oxime Ether Moiety

Synthesis, Biological Evaluation and In Silico Studies of Oxime Ether Derivatives Containing a Quinoxaline Moiety

Synthesis and Biological Activity of 1,3,4-Oxadiazole-substituted Pyridazinones

Synthesis, enzyme inhibition and molecular docking studies of novel 1,2,4-oxadiazole thioether derivatives

Synthesis and Biological Evaluation of New N-Acyl-α-amino Ketones and 1,3-Oxazoles Derivatives

Efficient Synthesis of Terminal Α,β-Unsaturated Ketones As the Intermediates of the Proteasome Epoxyketone Inhibitors Via Weinreb Amide

Synthesis, Structure and Antibacterial Activity of Novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone Oxime Ester Derivatives

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.

Design and synthesis of novel orexin 2 receptor agonists with a 1,3,5‑trioxazatriquinane skeleton

Synthesis And Antifungal Activity Of Novel 1,5-Diphenyl-1,4-Pentadien-3-One Oxime Esters

Synthesis and Biological Activity of Some New 1,3,4-Oxadiazoles Derived from Carboxylic Acids

Total Synthesis of an Epothilone Analogue based on the Amide‒Triazole Bioisosterism

Retraction of “asymmetric Synthesis of Apratoxin E”